India to United States: Levothyroxine Export Trade Route
India has recorded 722 verified shipments of Levothyroxine exported to United States, representing a combined trade value of $42.5M USD. This corridor is served by 10 active Indian exporters, with an average shipment value of $58.8K USD. The leading Indian exporter is MACLEODS PHARMACEUTICALS LTD, which accounts for 56% of total export value with 174 shipments worth $23.6M USD. On the buying side, MACLEODS PHARMA USA,INC, is the largest importer in United States with $21.6M USD in purchases. The top 3 suppliers — MACLEODS PHARMACEUTICALS LTD, INTAS PHARMACEUTICALS LIMITED, MYLAN LABORATORIES LIMITED — together control 84% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to United States Levothyroxine corridor is one of India's established pharmaceutical export routes, with 722 shipments documented worth a combined $42.5M USD. The route is dominated by MACLEODS PHARMACEUTICALS LTD, which alone accounts for roughly 56% of all export value, reflecting the consolidated nature of India's levothyroxine manufacturing sector.
Across 10 active suppliers, the average shipment value stands at $58.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with levothyroxine's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 12.3%, placing it at rank #1 among India's top levothyroxine export destinations globally.
On the import side, key buyers of Indian levothyroxine in United States include MACLEODS PHARMA USA,INC,, EVERSANA LIFE SCIENCES SERVICES,LLC, EVERSANA LIFE SCIENCES SERVICES LLC and 22 others. MACLEODS PHARMA USA,INC, is the single largest importer with 16 shipments valued at $21.6M USD.
Route Characteristics
- Average transit26 days
- Peak seasonQ1
- Primary modeSea freight
- Top portMUNDRA SEA
Market Position
- Global rank#1
- Annual growth+12.3%
- Demand growth+12.7%
- Regulatory ease83/100
Top 10 Indian Levothyroxine Exporters to United States
Showing top 10 of 10 Indian suppliers exporting Levothyroxine to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MACLEODS PHARMACEUTICALS LTD Avg $135.8K per shipment | 174 | $23.6M | 55.7% |
| 2 | INTAS PHARMACEUTICALS LIMITED Avg $23.8K per shipment | 380 | $9.0M | 21.3% |
| 3 | MYLAN LABORATORIES LIMITED Avg $51.6K per shipment | 60 | $3.1M | 7.3% |
| 4 | GLAND PHARMA LTD Avg $194.1K per shipment | 15 | $2.9M | 6.9% |
| 5 | LUPIN LIMITED Avg $50.2K per shipment | 41 | $2.1M | 4.8% |
| 6 | GLAND PHARMA LIMITED Avg $129.0K per shipment | 5 | $645.2K | 1.5% |
| 7 | ZYDUS LIFESCIENCES LIMITED Avg $157.0K per shipment | 4 | $628.1K | 1.5% |
| 8 | INTAS PHARMACEUTICALS LTD Avg $36.7K per shipment | 9 | $329.9K | 0.8% |
| 9 | MACLEODS PHARMACEUTICALS LIMITED Avg $4.1K per shipment | 33 | $136.3K | 0.3% |
| 10 | ALLMPUS LABORATORIES PRIVATE LIMITED Avg $239 per shipment | 1 | $239 | 0.0% |
This table shows the top 10 of 10 Indian companies exporting levothyroxine to United States, ranked by total trade value. The listed exporters are: MACLEODS PHARMACEUTICALS LTD, INTAS PHARMACEUTICALS LIMITED, MYLAN LABORATORIES LIMITED, GLAND PHARMA LTD, LUPIN LIMITED, GLAND PHARMA LIMITED, ZYDUS LIFESCIENCES LIMITED, INTAS PHARMACEUTICALS LTD, MACLEODS PHARMACEUTICALS LIMITED, ALLMPUS LABORATORIES PRIVATE LIMITED. MACLEODS PHARMACEUTICALS LTD is the dominant supplier with 174 shipments worth $23.6M USD, giving it a 56% market share. The top 3 suppliers together account for 84% of the total trade value on this route.
Top 10 Levothyroxine Importers in United States
Showing top 10 of 25 known buyers in United States receiving Levothyroxine shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian levothyroxine in United States include MACLEODS PHARMA USA,INC,, EVERSANA LIFE SCIENCES SERVICES,LLC, EVERSANA LIFE SCIENCES SERVICES LLC, Mylan Pharmaceuticals Inc 3711 Collins Ferry Road, EVERSANA LIFE SCIENCE SERVICES LLC, among 25 total buyers. The largest importer is MACLEODS PHARMA USA,INC,, accounting for $21.6M USD across 16 shipments — representing 51% of all levothyroxine imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MACLEODS PHARMA USA,INC, | 16 | $21.6M | 50.9% |
| 2 | EVERSANA LIFE SCIENCES SERVICES,LLC | 212 | $5.3M | 12.4% |
| 3 | EVERSANA LIFE SCIENCES SERVICES LLC | 107 | $3.2M | 7.6% |
| 4 | Mylan Pharmaceuticals Inc 3711 Collins Ferry Road | 42 | $2.3M | 5.4% |
| 5 | EVERSANA LIFE SCIENCE SERVICES LLC | 7 | $1.8M | 4.3% |
| 6 | EVERSANA | 11 | $1.7M | 4.1% |
| 7 | LUPIN INC | 27 | $1.4M | 3.3% |
| 8 | XXLANXXHARXXCEUXXCALXXINCXX371XXCOLXXNS XXRRYXXOAD | 18 | $795.5K | 1.9% |
| 9 | XXPINXXNC | 14 | $674.5K | 1.6% |
| 10 | MACLEODS PHARMA USA INC | 65 | $673.6K | 1.6% |
Showing top 10 of 25 Levothyroxine importers in United States on this route.
Top 10 Levothyroxine Formulations Imported by United States
Showing top 10 of 304 product formulations shipped on the India to United States Levothyroxine route, ranked by trade value
United States imports a wide range of levothyroxine formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — LEVOTHYROXINE SODIUM TABLETS USP 125 MCG1X1000S (1326 PAC) — accounts for $5.9M USD across 1 shipments. There are 304 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LEVOTHYROXINE SODIUM TABLETS USP 125 MCG1X1000S (1326 PAC) | 1 | $5.9M | 14.0% |
| 2 | LEVOTHYROXINE SODIUM TABLETS USP 137 MCG1X1000S (1348 PAC) | 1 | $5.4M | 12.8% |
| 3 | LEVOTHYROXINE SODIUM TABLETS USP 100 MCG1X1000S (1306 PAC) | 1 | $5.2M | 12.2% |
| 4 | LEVOTHYROXINE SODIUM TABLETS USP 112 MCG1X1000S (1311 PAC) | 1 | $5.0M | 11.8% |
| 5 | LEVOTHYROXINE SODIUM FOR INJ 100MCG/VIAL, 10ML VIALNOS | 7 | $879.3K | 2.1% |
| 6 | LEVOTHYROXINE SODIUM FOR INJECTION 100 MCG/VIAL, 10ML VIAL | 4 | $870.8K | 2.1% |
| 7 | LEVOTHYROXINE SOD TAB USP0.175MG 100S US | 6 | $658.3K | 1.5% |
| 8 | LEVOTHYROXINE SOD TAB USP 0.2MG 100S US | 6 | $530.6K | 1.2% |
| 9 | LEVOTHYROXINE SODIUM FOR INJECTION 100 MCG VIAL 10ML VIAL | 1 | $425.6K | 1.0% |
| 10 | LEVOTHYROXINE SODIUM FOR INJ 100MCG/VIAL, 10ML VIAL | 1 | $421.3K | 1.0% |
Showing top 10 of 304 Levothyroxine formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 79%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
MUNDRA SEA handles the highest volume with 225 shipments. Transit time averages 26 days by sea.
Market Dynamics
India's levothyroxine exports to United States are driven primarily by a handful of large-scale manufacturers. MACLEODS PHARMACEUTICALS LTD with 174 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 10 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — MACLEODS PHARMACEUTICALS LTD, INTAS PHARMACEUTICALS LIMITED, MYLAN LABORATORIES LIMITED — together account for 84% of total trade value on this route. The average shipment value of $58.8K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as levothyroxine sodium tablets usp 137 mcg1x1000s (1348 pac) and levothyroxine sodium tablets usp 100 mcg1x1000s (1306 pac), suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, MACLEODS PHARMA USA,INC, is the largest importer with 16 shipments worth $21.6M USD — representing 51% of all levothyroxine imports from India on this route. A total of 25 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $42.5M
- Avg. Shipment
- $58.8K
- Suppliers
- 10
- Buyers
- 25
- Transit (Sea)
- ~26 days
- Annual Growth
- +12.3%
Related Analysis
Reverse Direction
United States → India — Levothyroxine (Import)Other Levothyroxine Routes
Unlock the Full India to United States Levothyroxine Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 722 shipments on this route.
Frequently Asked Questions — India to United States Levothyroxine Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Levothyroxine to United States?
The leading Indian exporters of Levothyroxine to United States are MACLEODS PHARMACEUTICALS LTD, INTAS PHARMACEUTICALS LIMITED, MYLAN LABORATORIES LIMITED. MACLEODS PHARMACEUTICALS LTD holds the largest market share at approximately 56% of total trade value on this route.
Q What is the total value of Levothyroxine exports from India to United States?
India exports Levothyroxine to United States worth approximately $42.5M USD across 722 recorded shipments. The average value per shipment is $58.8K USD.
Q Which ports does India use to ship Levothyroxine to United States?
The most active port of origin is MUNDRA SEA with 225 shipments. Indian exporters primarily use sea freight for this route, with 79% of shipments going by sea and 26% by air.
Q How long does shipping take from India to United States for Levothyroxine?
The average transit time for Levothyroxine shipments from India to United States is approximately 26 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to United States Levothyroxine trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 12.3% with demand growth tracking at 12.7%. The route is ranked #1 among India's top Levothyroxine export destinations globally.
Q How many suppliers are active on the India to United States Levothyroxine route?
There are currently 10 active Indian suppliers exporting Levothyroxine to United States. The market is moderately concentrated with MACLEODS PHARMACEUTICALS LTD accounting for 56% of total shipment value.
Q Who are the main importers of Levothyroxine from India in United States?
The leading importers of Indian Levothyroxine in United States include MACLEODS PHARMA USA,INC,, EVERSANA LIFE SCIENCES SERVICES,LLC, EVERSANA LIFE SCIENCES SERVICES LLC, Mylan Pharmaceuticals Inc 3711 Collins Ferry Road, EVERSANA LIFE SCIENCE SERVICES LLC. MACLEODS PHARMA USA,INC, is the largest buyer with 16 shipments worth $21.6M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Levothyroxine.
- 2.Supplier/Buyer Matching: 10 Indian exporters and 25 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 722 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
722 Verified Shipments
10 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists